Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Wall Street
Price Targets
TORNTPHARM Price Targets Summary
Torrent Pharmaceuticals Ltd
According to Wall Street analysts, the average 1-year price target for TORNTPHARM is 2 630.9748 INR with a low forecast of 1 545.3 INR and a high forecast of 3 123.75 INR.
Price Targets
Operating Income
Forecast
Operating Income Estimate
Torrent Pharmaceuticals Ltd
For the last 8 years the compound annual growth rate for Torrent Pharmaceuticals Ltd's operating income is 13%. The projected CAGR for the next 4 years is 18%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is TORNTPHARM's stock price target?
Price Target
2 630.9748
INR
According to Wall Street analysts, the average 1-year price target for TORNTPHARM is 2 630.9748 INR with a low forecast of 1 545.3 INR and a high forecast of 3 123.75 INR.
What is Torrent Pharmaceuticals Ltd's Revenue forecast?
Projected CAGR
13%
For the last 8 years the compound annual growth rate for Torrent Pharmaceuticals Ltd's revenue is 10%. The projected CAGR for the next 4 years is 13%.
What is Torrent Pharmaceuticals Ltd's Operating Income forecast?
Projected CAGR
18%
For the last 8 years the compound annual growth rate for Torrent Pharmaceuticals Ltd's operating income is 13%. The projected CAGR for the next 4 years is 18%.
What is Torrent Pharmaceuticals Ltd's Net Income forecast?
Projected CAGR
26%
For the last 8 years the compound annual growth rate for Torrent Pharmaceuticals Ltd's net income is 7%. The projected CAGR for the next 4 years is 26%.